Peptide Mapping
Using Peptide Maps to Truly Understand Biopharmaceutical Stability
Understanding biopharmaceutical stability is one of the most critical and challenging aspects of biopharmaceutical development. These days, thorough characterization of degradants is not just important to decision-making, it is a regulatory mandate.
ABC Laboratories' Biotech Services team has been conducting peptide mapping assays for a combined 40 years, and we understand the challenges of biopharmaceutical stability. So when degradation is detected, ABC's biotech experts can do more than deliver data--they will correlate degradants to the bioactivity of the drug, assess their effects and help you choose a path forward.
ABC's large molecule experience, combined with our use of cutting-edge UPLC chromatographic systems delivers fast, accurate results.
We offer:
- The latest Waters UPLC chromatographic systems for ultra-high resolution of peptides
- Waters Premier XCT ES-High Resolution TOF-MS Analyzer
- Several Sciex 4000 QTRAP® detectors
Why UPLC is Better
UPLC systems provide faster results with better resolution to easily identify degradants, giving you well-defined, more precise results for more informed decision-making. ABC's use of UPLC systems is coupled with UV and MS or MS/MS backend analysis to reduce analytical variation and increase analytical efficiency.
|
